Cross-sectional study shows a significant decrease in cervical cancer diagnoses during COVID-19 pandemic, highlighting urgent healthcare disparities.
Objectives: to verify the impact of the COVID-19 pandemic on the diagnosis of cervical cancer and changes in the number of histopathological exams performed in the years 2019 to 2020 in the city of Araguaína-Tocantins. Methods: cross-sectional, descriptive and quantitative epidemiological study about the registered numbers of cervical cancer in the city of Araguaína – Tocantins in the period from 2019 to 2021 of the COVID-19 pandemic. Data collection was carried out in April 2022, through INCA and DATASUS. The analyzed inclusion variables were: number of new cases per year and histological type of malignant neoplasm (squamous cell carcinoma and adenocarcinoma). Results: between the period from 2019 to 2021, there was a 33.5% drop in the number of histopathological exams performed in the city of Araguaína-TO, on the other hand, there was a significant decrease in the recorded numbers of severe lesions of the uterine cervix (NIC III) during the same period. When it comes to histological subtypes, there was only one case of each type of adenocarcinoma and a 75% drop in the invasive epidermoid type compared to the time before the pandemic. Conclusion: it is clear, therefore, that the spread of COVID-19 changed health care and diagnosis of uterine cancer in the Araguainense population. Keywords: Epidemiological Study. Cancer. Cervix.
No takes yet. Share an insight, caveat, or question.
Filatier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: